| P50 | author | Francisco Carrillo-Salinas | Q56241066 |
| P2093 | author name string | Carmen Guaza | |
| | Leyre Mestre | |
| | Miriam Mecha | |
| | Carmen Espejo | |
| | Ana Feliú | |
| | Luisa María Villar | |
| | José Carlos Álvarez-Cermeño | |
| P2860 | cites work | QIIME allows analysis of high-throughput community sequencing data | Q24616873 |
| | Theiler's virus infection: a model for multiple sclerosis | Q24629115 |
| | "Microglial nodules" and "newly forming lesions" may be a Janus face of early MS lesions; implications from virus-induced demyelination, the Inside-Out model | Q26779366 |
| | The role of gut microbiota in immune homeostasis and autoimmunity | Q26860722 |
| | Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis | Q29547656 |
| | Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences | Q29615050 |
| | Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis | Q29619978 |
| | 2-Arachidonoylglycerol Reduces Proteoglycans and Enhances Remyelination in a Progressive Model of Demyelination. | Q40104988 |
| | Fingolimod increases CD39-expressing regulatory T cells in multiple sclerosis patients | Q42012792 |
| | Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. | Q42221329 |
| | Gut microbiota from multiple sclerosis patients enables spontaneous autoimmune encephalomyelitis in mice | Q42263596 |
| | Two rheumatoid arthritis-specific autoantigens correlate microbial immunity with autoimmune responses in joints | Q42644114 |
| | CD39+Foxp3+ regulatory T Cells suppress pathogenic Th17 cells and are impaired in multiple sclerosis | Q43241046 |
| | An endocannabinoid tone limits excitotoxicity in vitro and in a model of multiple sclerosis | Q43265002 |
| | Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity. | Q43684750 |
| | Antibody response against gastrointestinal antigens in demyelinating diseases of the central nervous system. | Q43849229 |
| | A cannabinoid agonist interferes with the progression of a chronic model of multiple sclerosis by downregulating adhesion molecules. | Q44124410 |
| | Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons | Q44433866 |
| | Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice | Q45740050 |
| | Dexamethasone regulation of interleukin-1-receptors in the hippocampus of Theiler's virus-infected mice: effects on virus-mediated demyelination | Q45748847 |
| | Persistent infection of oligodendrocytes in Theiler's virus‐induced encephalomyelitis | Q45796139 |
| | Gut microbiome in multiple sclerosis: The players involved and the roles they play. | Q47100520 |
| | Microbiome Influences Prenatal and Adult Microglia in a Sex-Specific Manner | Q47560330 |
| | A commensal bacterial product elicits and modulates migratory capacity of CD39(+) CD4 T regulatory subsets in the suppression of neuroinflammation | Q48669047 |
| | Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. | Q48819558 |
| | Alteration of CD39+Foxp3+ CD4 T cell and cytokine levels in EAE/MS following anti-CD52 treatment. | Q51191912 |
| | A CB₁/CB₂ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin. | Q52625009 |
| | Human Gut-Derived Commensal Bacteria Suppress CNS Inflammatory and Demyelinating Disease. | Q52759565 |
| | Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. | Q54412643 |
| | Th1/Th17 immune response is induced by mesenteric lymph node dendritic cells in Crohn's disease. | Q54471973 |
| | The human gut microbiome in early-onset type 1 diabetes from the TEDDY study | Q57807205 |
| | Targeted Diet Modification Reduces Multiple Sclerosis-like Disease in Adult Marmoset Monkeys from an Outbred Colony | Q57810583 |
| | The Gut-Microglia Connection: Implications for Central Nervous System Diseases | Q57817925 |
| | Vitamin D–Dependent Rickets, HLA-DRB1, and the Risk of Multiple Sclerosis | Q57912274 |
| | Microbiome-microglia connections via the gut-brain axis | Q58559445 |
| | Role of gut commensal microflora in the development of experimental autoimmune encephalomyelitis | Q84749218 |
| | B cells in multiple sclerosis | Q88305700 |
| | Gut environmental factors and multiple sclerosis | Q90753840 |
| | Short-chain fatty acids and gut microbiota in multiple sclerosis | Q93066507 |
| | Metagenomic analyses reveal antibiotic-induced temporal and spatial changes in intestinal microbiota with associated alterations in immune cell homeostasis | Q30920058 |
| | A novel probiotic mixture exerts a therapeutic effect on experimental autoimmune encephalomyelitis mediated by IL-10 producing regulatory T cells | Q33528981 |
| | Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. | Q34360221 |
| | Host microbiota constantly control maturation and function of microglia in the CNS. | Q34478756 |
| | Induction of a regulatory B cell population in experimental allergic encephalomyelitis by alteration of the gut commensal microflora | Q34503563 |
| | The microbiota in adaptive immune homeostasis and disease | Q34533142 |
| | Uncovering effects of antibiotics on the host and microbiota using transkingdom gene networks | Q34667649 |
| | Depletion of murine intestinal microbiota: effects on gut mucosa and epithelial gene expression | Q34704203 |
| | Multiple sclerosis: an immune or neurodegenerative disorder? | Q34786872 |
| | Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression | Q34831296 |
| | Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus-induced demyelinating disease model of multiple sclerosis | Q35172044 |
| | STAMP: statistical analysis of taxonomic and functional profiles. | Q35212955 |
| | Gut microbiome and multiple sclerosis. | Q35245013 |
| | Peripheral education of the immune system by colonic commensal microbiota. | Q35341308 |
| | Segregated regulatory CD39+CD4+ T cell function: TGF-β-producing Foxp3- and IL-10-producing Foxp3+ cells are interdependent for protection against collagen-induced arthritis | Q35610749 |
| | Dysbiosis in the Gut Microbiota of Patients with Multiple Sclerosis, with a Striking Depletion of Species Belonging to Clostridia XIVa and IV Clusters | Q35773313 |
| | Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine. | Q35816184 |
| | Gut microbiota, metabolites and host immunity | Q36031926 |
| | A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function | Q36191738 |
| | The dual role of short fatty acid chains in the pathogenesis of autoimmune disease models | Q36289990 |
| | High cell surface expression of CD4 allows distinction of CD4(+)CD25(+) antigen-specific effector T cells from CD4(+)CD25(+) regulatory T cells in murine experimental autoimmune encephalomyelitis | Q36401977 |
| | Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls | Q37040077 |
| | Alterations of the human gut microbiome in multiple sclerosis. | Q37060934 |
| | NKT cell-dependent amelioration of a mouse model of multiple sclerosis by altering gut flora | Q37061082 |
| | B-lymphocyte contributions to human autoimmune disease | Q37211283 |
| | Induction of gut regulatory CD39+ T cells by teriflunomide protects against EAE. | Q37337770 |
| | Gut dysbiosis and neuroimmune responses to brain infection with Theiler's murine encephalomyelitis virus. | Q37698703 |
| | Environmental factors in multiple sclerosis | Q38167388 |
| | Microglial diversity by responses and responders | Q38205433 |
| | Environmental risk factors and multiple sclerosis: an umbrella review of systematic reviews and meta-analyses | Q38348320 |
| | Influence of the Gut Microbiome on Autoimmunity in the Central Nervous System | Q38772593 |
| | The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease | Q38926183 |
| | The gut microbiome in multiple sclerosis | Q39021579 |
| | Mesenteric lymph nodes contribute to proinflammatory Th17-cell generation during inflammation of the small intestine in mice | Q39124619 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P921 | main subject | motor disability | Q106097353 |
| P304 | page(s) | 1374 | |
| P577 | publication date | 2019-06-14 | |
| P1433 | published in | Frontiers in Immunology | Q27723748 |
| P1476 | title | Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis | |
| P478 | volume | 10 | |